About GBI
GBI is a company based in Plantation (United States) founded in 1992. It operates as a Managed Services. GBI has raised $30.73 million across 4 funding rounds from investors including Signet Healthcare Partners. The company has 62 employees as of December 31, 2021. GBI offers products and services including Biopharmaceutical Manufacturing, Bioconjugation, and Aseptic Fill & Finish. GBI operates in a competitive market with competitors including Novartis, Catalent, Surrozen, Biotage and Curia, among others.
- Headquarter Plantation, United States
- Employees 62 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Goodwin Biotechnology Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$30.73 M (USD)
in 4 rounds
-
Latest Funding Round
$2 M (USD), Unspecified
Dec 05, 2025
- Investors
-
Employee Count
62
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GBI
GBI offers a comprehensive portfolio of products and services, including Biopharmaceutical Manufacturing, Bioconjugation, and Aseptic Fill & Finish. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Services for manufacturing biopharmaceuticals are provided by GBI.
Bioconjugation solutions are offered for complex biologic development.
Aseptic filling and finishing services are provided by GBI.
Funding Insights of GBI
GBI has successfully raised a total of $30.73M across 4 strategic funding rounds. The most recent funding activity was a Unspecified round of $2 million completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Unspecified — $2.0M
-
First Round
First Round
(30 Apr 2019)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2025 | Amount | Unspecified - GBI | Valuation |
investors |
|
| Nov, 2024 | Amount | Unspecified - GBI | Valuation |
investors |
|
| Oct, 2023 | Amount | Unspecified - GBI | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in GBI
GBI has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Signet Healthcare Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm investing in North America and Europe
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GBI
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - GBI
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Gbi Comparisons
Competitors of GBI
GBI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novartis, Catalent, Surrozen, Biotage and Curia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
|
| domain | founded_year | HQ Location |
CDMO offering drug and biologics development services
|
|
| domain | founded_year | HQ Location |
Selective Wnt agonists are developed for human tissue regeneration.
|
|
| domain | founded_year | HQ Location |
Organic synthesis, analytical, and peptide chemistry services for drug discovery and development
|
|
| domain | founded_year | HQ Location |
Drug research, development, testing, and consulting services are provided.
|
|
| domain | founded_year | HQ Location |
Provides contract research, development, and manufacturing services for biologic drugs.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Gbi
Frequently Asked Questions about GBI
When was GBI founded?
GBI was founded in 1992 and raised its 1st funding round 27 years after it was founded.
Where is GBI located?
GBI is headquartered in Plantation, United States. It is registered at Plantation, Florida, United States.
Who is the current CEO of GBI?
Darrin T Schellin is the current CEO of GBI.
Is GBI a funded company?
GBI is a funded company, having raised a total of $30.73M across 4 funding rounds to date. The company's 1st funding round was a Unspecified of $5M, raised on Apr 30, 2019.
How many employees does GBI have?
As of Dec 31, 2021, the latest employee count at GBI is 62.
What does GBI do?
GBI, formerly known as Goodwin Biotechnology Inc., is established as a full-service biopharmaceutical CDMO headquartered in Plantation, Florida, USA. The company is focused on providing comprehensive contract development and manufacturing services for complex biologic therapeutics. Services offered include upstream processing, cell culture development, cGMP cell banking, DSP purification, bioconjugation, aseptic fill and finish, and stability testing. Support services such as manufacturing strategy development, project management, regulatory and CMC support, quality control, and biomanufacturing planning are also provided. GBI operates in the healthcare sector, specifically targeting biotechnology and biopharmaceuticals, aiming to eliminate manufacturing risks for its clients through expert teams and state-of-the-art equipment.
What products or services does GBI offer?
GBI offers Biopharmaceutical Manufacturing, Bioconjugation, and Aseptic Fill & Finish.
Who are GBI's investors?
GBI has 1 investor. Key investors include Signet Healthcare Partners.